The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?
Carole Luthold1,2, Tarek Hallal3, David P Labbé3,4
1Centre de Recherche sur le Cancer, Université Laval, Québec, QC G1R 3S3, Canada.
Abstract:
Despite advancements made in diagnosis and treatment, prostate cancer remains the second most diagnosed cancer among men worldwide in 2020, and the first in North America and Europe. Patients with localized disease usually respond well to first-line treatments, however, up to 30% develop castration-resistant prostate cancer (CRPC), which is often metastatic, making this stage of the disease incurable and ultimately fatal. Over the last years, interest has grown into the extracellular matrix (ECM) stiffening as an important mediator of diseases, including cancers. While this process is increasingly well-characterized in breast cancer, a similar in-depth look at ECM stiffening remains lacking for prostate cancer. In this review, we scrutinize the current state of literature regarding ECM stiffening in prostate cancer and its potential association with disease progression and castration resistance.
Related Concept Videos
The Tumor Microenvironment
Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Role of Matrix Metalloproteases in Degradation of ECM
Overview of Cell-Matrix Interactions


